Protocol Ledger

NCT03668041 · Phase III · COMPLETED

National Adaptive Trial for PTSD Related Insomnia

Interventional Phase III clinical trial protocol NCT03668041 sponsored by VA Office of Research and Development in Neurology, Psychiatry, and Pain, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2021-02-25 Enrollment: 673 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT03668041
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)673 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)0 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT03668041
Protocol FieldVerified Registry Value
NCT IdentifierNCT03668041
Consolidated Lead SponsorVA Office of Research and Development
Therapeutic Condition CohortNeurology, Psychiatry, and Pain
Clinical Trial PhasePhase III
Overall Recruitment StatusCOMPLETED
Registered Enrollment673 participants (ACTUAL)
Registered Start Date2021-02-25
WhyStopped ClassificationNot Stopped

Search related sites and sponsors in the Interactive Directory, explore Neurology, Psychiatry, and Pain Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI